Fundraising Fox

Clear.bio

operating company · company profile

Amsterdam

Fox Verdict
Sign up to see your fit

Investment thesis

Clear.bio develops technology-enabled solutions for type 2 diabetes management, combining personalized nutrition guidance with data-driven insights from continuous glucose monitoring. The company's approach focuses on addressing the root causes of type 2 diabetes rather than symptom management, enabling patients to achieve remission and improved health outcomes through behavioral change. The platform integrates scientific expertise in nutrition and metabolic health with digital tools to make personalized diabetes care accessible and scalable.

Source: firm website, verified Aug 6, 2026.

HQ
Amsterdam, NL

Frequently asked questions

What sectors does Clear.bio focus on?
Clear.bio focuses on Digital Health, Healthtech.
Where is Clear.bio located?
Clear.bio is headquartered in Amsterdam, NL.

Media · Podcasts & interviews

from their channel

BBC Al Jazeera: Clear on personalised nutrition

Clear bio - Diabetes Type 2 Management

Why Mustard Seed Maze invested in Clear

Clear bio - Diabetes Type 2 Management

Clear @ TNW 2021

Clear bio - Diabetes Type 2 Management

Images

Clear.bio photoClear.bio photoClear.bio photo

Co-investors · 1

Antler

Antler is a global early-stage venture capital firm that backs founders from the first check through to IPO, operating across roughly 30 locations worldwide.

$3M – $10M

Firms observed investing alongside Clear.bio, from public investor directories. Shared companies are the overlap with Clear.bio's recorded portfolio.

Similar investors

Featured in lists